U.S. Breast Biopsy Device Market
|発行||iData Research Inc.||商品コード||253594|
|出版日||ページ情報||英文 68 Pages
In 2010, there were over 1.6 million breast biopsy procedures performed in the U.S., less than in 2009, however procedures are expected to increase.
Breast imaging is essential for the detection of potentially cancerous abnormalities in the breast. While mammography has been invaluable for cancer screening, improving the technology of breast imaging has been the focus of many companies for a number of years. Different imaging modalities are now being used as supplementary tools to mammography, improving the options available for hard-to-diagnose patients.
This report pertains to a forecast period of 10 years (2007 - 2017) for the U.S.
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our "bottom up" approach, which includes primary and secondary research methods.